WO2001077684A3 - Proteomic analysis using activity-based probe libraries - Google Patents

Proteomic analysis using activity-based probe libraries Download PDF

Info

Publication number
WO2001077684A3
WO2001077684A3 PCT/US2000/034187 US0034187W WO0177684A3 WO 2001077684 A3 WO2001077684 A3 WO 2001077684A3 US 0034187 W US0034187 W US 0034187W WO 0177684 A3 WO0177684 A3 WO 0177684A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
probes
activity
libraries
specificity
Prior art date
Application number
PCT/US2000/034187
Other languages
French (fr)
Other versions
WO2001077684A2 (en
Inventor
Benjamin F Cravatt
Erik Sorensen
Matthew Patricelli
Martha Lovato
Gregory Adam
Original Assignee
Scripps Research Inst
Benjamin F Cravatt
Erik Sorensen
Matthew Patricelli
Martha Lovato
Gregory Adam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst, Benjamin F Cravatt, Erik Sorensen, Matthew Patricelli, Martha Lovato, Gregory Adam filed Critical Scripps Research Inst
Priority to AU2001227280A priority Critical patent/AU2001227280A1/en
Priority to EP00990226A priority patent/EP1275006A2/en
Priority to JP2001574487A priority patent/JP2003530365A/en
Priority to CA002403296A priority patent/CA2403296A1/en
Publication of WO2001077684A2 publication Critical patent/WO2001077684A2/en
Publication of WO2001077684A3 publication Critical patent/WO2001077684A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/557—Immunoassay; Biospecific binding assay; Materials therefor using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/30—Detection of binding sites or motifs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/16—Phosphorus containing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/18—Sulfur containing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides methods for analyzing proteomes, as cells or lysates. The analysis is based on the use of probes that have specificity to the active form of proteins, particularly enzymes and receptors. The probes can be identified in different ways. In accordance with the present invention, a method is provided for generating and screening compound libraries that are used for the identification of lead molecules, and for the parallel identification of their biological targets. By appending specific functionalities and/or groups to one or more binding moieties, the reactive functionalities gain binding affinity and specificity for particular proteins and classes of proteins. Such libraries of candidate compounds, referred to herein as activity-based probes, or ABPs, are used to screen for one or more desired biological activities or target proteins.
PCT/US2000/034187 2000-04-10 2000-12-15 Proteomic analysis using activity-based probe libraries WO2001077684A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2001227280A AU2001227280A1 (en) 2000-04-10 2000-12-15 Proteomic analysis using activity-based probe libraries
EP00990226A EP1275006A2 (en) 2000-04-10 2000-12-15 Proteomic analysis using activity-based probe libraries
JP2001574487A JP2003530365A (en) 2000-04-10 2000-12-15 Proteomic analysis
CA002403296A CA2403296A1 (en) 2000-04-10 2000-12-15 Proteomic analysis using activity-based probe libraries

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US19595400P 2000-04-10 2000-04-10
US60/195,954 2000-04-10
US21289100P 2000-06-20 2000-06-20
US60/212,891 2000-06-20
US22253200P 2000-08-02 2000-08-02
US60/222,532 2000-08-02

Publications (2)

Publication Number Publication Date
WO2001077684A2 WO2001077684A2 (en) 2001-10-18
WO2001077684A3 true WO2001077684A3 (en) 2002-09-12

Family

ID=27393542

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2000/034187 WO2001077684A2 (en) 2000-04-10 2000-12-15 Proteomic analysis using activity-based probe libraries
PCT/US2000/034167 WO2001077668A2 (en) 2000-04-10 2000-12-15 Proteomic analysis using active-site directed probes

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2000/034167 WO2001077668A2 (en) 2000-04-10 2000-12-15 Proteomic analysis using active-site directed probes

Country Status (6)

Country Link
US (5) US20020045194A1 (en)
EP (1) EP1275006A2 (en)
JP (1) JP2003530365A (en)
AU (2) AU2001224349A1 (en)
CA (1) CA2403296A1 (en)
WO (2) WO2001077684A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034798B2 (en) 2003-01-16 2015-05-19 Caprotec Bioanalytics Gmbh Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090118139A1 (en) * 2000-11-07 2009-05-07 Caliper Life Sciences, Inc. Microfluidic method and system for enzyme inhibition activity screening
AU2002247097A1 (en) * 2001-02-05 2002-08-19 Activx Biosciences, Inc. Activity based probe analysis
US7179655B2 (en) 2001-03-02 2007-02-20 Activx Biosciences, Inc. Protein profiling platform
US7381535B2 (en) * 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
WO2003067210A2 (en) 2001-07-10 2003-08-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting the activation state of the multiple proteins in single cells
US7393656B2 (en) * 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
US6800449B1 (en) * 2001-07-13 2004-10-05 Syngenta Participations Ag High throughput functional proteomics
EP2053406A3 (en) 2001-07-16 2009-06-24 caprotec bioanalytics GmbH Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
AU2002350650A1 (en) * 2001-11-09 2003-05-19 Bayer Aktiengesellschaft Isotopically coded affinity marker 2
US20030143648A1 (en) * 2001-11-29 2003-07-31 Cravatt Benjamin F. Enzyme activity profiles
DE10200374A1 (en) * 2002-01-08 2003-07-24 Friz Biochem Gmbh Method for the qualitative and quantitative comparative detection of chemical substances
WO2003069345A2 (en) * 2002-02-12 2003-08-21 Biotesys Gmbh Analysis of a protein expression pattern
US7504364B2 (en) * 2002-03-01 2009-03-17 Receptors Llc Methods of making arrays and artificial receptors
AU2003225799A1 (en) * 2002-03-03 2003-09-29 Activx Biosciences, Inc. Tethered activity-based probes and uses thereof
DE60325847D1 (en) * 2002-03-11 2009-03-05 Caprotec Bioanalytics Gmbh COMPOUNDS AND PROCEDURES FOR THE ANALYSIS OF THE PROTEOM
AU2003232447A1 (en) * 2002-05-31 2003-12-19 Advanced Research And Technology Institute, Inc. Use of reagent homologs for comparative proteomics
GB0213614D0 (en) * 2002-06-13 2002-07-24 Novartis Forschungsstiftlung Z Purified PKB Kinae and uses thereof
EP1546359A4 (en) 2002-09-12 2007-05-09 Molecular Probes Inc Site-specific labeling of affinity tags in fusion proteins
US20060057625A1 (en) * 2002-09-16 2006-03-16 Carlson Robert E Scaffold-based artificial receptors and methods
US20060051802A1 (en) * 2002-09-16 2006-03-09 Receptors Llc Artificial receptors, building blocks, and methods
US20050170385A1 (en) * 2002-09-16 2005-08-04 Receptors Llc Artificial receptors including gradients
US20040137481A1 (en) * 2002-09-16 2004-07-15 Receptors Llc Artificial receptor building blocks, components, and kits
US20050037381A1 (en) * 2002-09-16 2005-02-17 Receptors Llc Artificial receptors, building blocks, and methods
US20050037429A1 (en) * 2003-03-28 2005-02-17 Receptors Llc Artificial receptors including reversibly immobilized building blocks and methods
US7923433B2 (en) 2002-10-09 2011-04-12 Activx Biosciences, Inc. Activity-based probes and methods of their preparation and use
AU2003286553A1 (en) * 2002-10-18 2004-05-04 Promega Corporation Methods for separating molecules
ATE466953T1 (en) * 2003-01-17 2010-05-15 Advanced Proteome Therapeutics METHOD FOR IDENTIFYING ACTIVATED POLYMER COMPLEXES FOR SECONDARY SITE-SPECIFIC MODIFICATION OF PROTEIN TARGET GROUPS.
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
JP4748685B2 (en) 2003-01-31 2011-08-17 プロメガ コーポレイション Covalent tethering of functional groups to proteins
WO2004079370A1 (en) * 2003-03-03 2004-09-16 Universiteit Leiden Analysis of the proteome of a living cell by labelling the proteins in the intact cell
TW200508936A (en) * 2003-03-12 2005-03-01 Bionova Corp The establishment of proteome structure profile databases and their uses
EP1613737A4 (en) * 2003-03-28 2008-12-03 Receptors Llc Artificial receptors including reversibly immobilized building blocks and methods
US7365178B2 (en) 2003-04-01 2008-04-29 Activx Biosciences, Inc. Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis
WO2005040163A1 (en) 2003-10-28 2005-05-06 Dr. Reddy's Laboratories Ltd Heterocyclic compounds that block the effects of advanced glycation end products (age)
US7413868B2 (en) * 2003-11-05 2008-08-19 Trellis Bioscience, Inc. Use of particulate labels in bioanalyte detection methods
JP2005172694A (en) 2003-12-12 2005-06-30 Fuji Photo Film Co Ltd Protein detection method
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
US7884052B2 (en) * 2004-09-03 2011-02-08 Receptors Llc Combinatorial artificial receptors including tether building blocks on scaffolds
WO2006029383A2 (en) * 2004-09-11 2006-03-16 Receptors Llc Combinatorial artificial receptors including peptide building blocks
US8216804B2 (en) * 2004-10-27 2012-07-10 The Scripps Research Institute Orthogonal translation components for the in vivo incorporation of unnatural amino acids
US20070009923A1 (en) * 2005-01-24 2007-01-11 Massachusetts Institute Of Technology Use of bayesian networks for modeling cell signaling systems
AU2006259153B2 (en) 2005-06-14 2012-04-12 Cellzome Gmbh Process for the identification of novel enzyme interacting compounds
EP1734367A1 (en) 2005-06-14 2006-12-20 Cellzome Ag Process for the identification of novel enzyme interacting compounds
US20070048786A1 (en) * 2005-09-01 2007-03-01 Arnon Chait Systems and methods for fractionation of protein mixtures
WO2007050052A2 (en) * 2005-10-25 2007-05-03 Norman Leigh Anderson Process for treatment of protein samples
US20070092924A1 (en) * 2005-10-25 2007-04-26 Anderson Norman L Process for treatment of protein samples
US20080171666A1 (en) * 2007-01-11 2008-07-17 Council Of Scientific And Industrial Research Method for developing a tissue proteome library
WO2008048345A2 (en) * 2006-02-14 2008-04-24 Perkinelmer Las, Inc. Detection systems for mass labels
US20080319678A1 (en) * 2006-02-15 2008-12-25 University Of Virginia Patent Foundation Mass Tagging for Quantitative Analysis of Biomolecules using 13C Labeled Phenylisocyanate
CA2665223A1 (en) * 2006-10-02 2008-05-29 The Scripps Research Institute An enzyme regulating ether lipid signaling pathways
US20080234223A1 (en) * 2006-10-30 2008-09-25 University Of Southern California N4 modifications of pyrimidine analogs and uses thereof
CA2667697A1 (en) 2006-10-30 2008-05-08 Promega Corporation Mutant hydrolase proteins with enhanced kinetics and functional expression
GB2474146B (en) * 2008-04-29 2013-04-10 Nodality Inc Methods of determining the health status of an individual
WO2010006291A1 (en) 2008-07-10 2010-01-14 Nodality, Inc. Methods for diagnosis, prognosis and treatment
US8399206B2 (en) 2008-07-10 2013-03-19 Nodality, Inc. Methods for diagnosis, prognosis and methods of treatment
EP2394175B1 (en) 2009-02-09 2016-02-03 caprotec bioanalytics GmbH Devices, systems and methods for separating magnetic particles
US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays
PL2556171T3 (en) 2010-04-05 2016-04-29 Prognosys Biosciences Inc Spatially encoded biological assays
US20190300945A1 (en) 2010-04-05 2019-10-03 Prognosys Biosciences, Inc. Spatially Encoded Biological Assays
KR101744339B1 (en) * 2010-05-03 2017-06-08 삼성전자주식회사 Surface Acoustic Wave Sensor Device Including Target Biomolecule Isolation Component
EP2685969A4 (en) 2011-03-18 2014-08-06 Catabasis Pharmaceuticals Inc Use of intracellular enzymes for the release of covalently linked bioactives
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
US20140170653A1 (en) 2011-04-15 2014-06-19 Life Technologies Corporation Chemical ligation
US8642951B2 (en) 2011-05-04 2014-02-04 Agilent Technologies, Inc. Device, system, and method for reflecting ions
US20130123131A1 (en) * 2011-11-09 2013-05-16 Nodality, Inc. Process for Ensuring Consistency and Reproducibility of a Diagnostic or Research Method
US9868979B2 (en) 2013-06-25 2018-01-16 Prognosys Biosciences, Inc. Spatially encoded biological assays using a microfluidic device
JP6203295B2 (en) * 2014-02-10 2017-09-27 Jsr株式会社 Target substance capturing method, solid phase carrier for capturing target substance, and method for producing the solid phase carrier
CN104880357A (en) * 2014-02-28 2015-09-02 中国科学院过程工程研究所 Preparation method of quartz capillary affinity chromatography column
ES2955916T3 (en) 2015-04-10 2023-12-11 Spatial Transcriptomics Ab Multiplex analysis of biological specimens of spatially distinguished nucleic acids
CN105527359B (en) * 2015-11-19 2017-10-31 云南民族大学 Protein secondary Mass Spectrometric Identification method based on positive and negative planting modes on sink characteristic information matches
CN111433176B (en) 2017-10-04 2023-08-29 巴特尔纪念研究院 Probes for selectively characterizing enzymes involved in xenobiotic metabolism and methods of making and using the same
US11155573B2 (en) 2017-10-13 2021-10-26 Battelle Memorial Institute Bile salt hydrolase probe and method of making and using the same
EP3694528A4 (en) 2017-10-13 2021-07-28 The Regents of the University of California Mtorc1 modulators
US11226337B2 (en) 2017-10-31 2022-01-18 Zenagem, LLC Chemoproteomic profiling of protein electrophilic and oxidative post-translational modifications
US11519033B2 (en) 2018-08-28 2022-12-06 10X Genomics, Inc. Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample
EP3894592A2 (en) 2018-12-10 2021-10-20 10X Genomics, Inc. Generating spatial arrays with gradients
JP2022515728A (en) * 2018-12-20 2022-02-22 武田薬品工業株式会社 A novel activity-based probe for neutrophil elastase and its use
US11649485B2 (en) 2019-01-06 2023-05-16 10X Genomics, Inc. Generating capture probes for spatial analysis
US11926867B2 (en) 2019-01-06 2024-03-12 10X Genomics, Inc. Generating capture probes for spatial analysis
CN112930568A (en) * 2019-04-23 2021-06-08 艾斯皮雷科技股份有限公司 Device and method for locating or identifying malignant tumors
EP3976820A1 (en) 2019-05-30 2022-04-06 10X Genomics, Inc. Methods of detecting spatial heterogeneity of a biological sample
CN111579796A (en) * 2020-05-19 2020-08-25 南方科技大学 High-throughput integrated phosphorylation proteomics detection method
WO2021091611A1 (en) 2019-11-08 2021-05-14 10X Genomics, Inc. Spatially-tagged analyte capture agents for analyte multiplexing
EP4025711A2 (en) 2019-11-08 2022-07-13 10X Genomics, Inc. Enhancing specificity of analyte binding
EP3891300B1 (en) 2019-12-23 2023-03-29 10X Genomics, Inc. Methods for spatial analysis using rna-templated ligation
US11732299B2 (en) 2020-01-21 2023-08-22 10X Genomics, Inc. Spatial assays with perturbed cells
US11702693B2 (en) 2020-01-21 2023-07-18 10X Genomics, Inc. Methods for printing cells and generating arrays of barcoded cells
US11821035B1 (en) 2020-01-29 2023-11-21 10X Genomics, Inc. Compositions and methods of making gene expression libraries
US11898205B2 (en) 2020-02-03 2024-02-13 10X Genomics, Inc. Increasing capture efficiency of spatial assays
US11732300B2 (en) 2020-02-05 2023-08-22 10X Genomics, Inc. Increasing efficiency of spatial analysis in a biological sample
US11835462B2 (en) 2020-02-11 2023-12-05 10X Genomics, Inc. Methods and compositions for partitioning a biological sample
US11891654B2 (en) 2020-02-24 2024-02-06 10X Genomics, Inc. Methods of making gene expression libraries
US11926863B1 (en) 2020-02-27 2024-03-12 10X Genomics, Inc. Solid state single cell method for analyzing fixed biological cells
US11768175B1 (en) 2020-03-04 2023-09-26 10X Genomics, Inc. Electrophoretic methods for spatial analysis
ES2965354T3 (en) 2020-04-22 2024-04-12 10X Genomics Inc Methods for spatial analysis using targeted RNA deletion
AU2021275906A1 (en) 2020-05-22 2022-12-22 10X Genomics, Inc. Spatial analysis to detect sequence variants
WO2021236929A1 (en) 2020-05-22 2021-11-25 10X Genomics, Inc. Simultaneous spatio-temporal measurement of gene expression and cellular activity
WO2021242834A1 (en) 2020-05-26 2021-12-02 10X Genomics, Inc. Method for resetting an array
EP4158054A1 (en) 2020-06-02 2023-04-05 10X Genomics, Inc. Spatial transcriptomics for antigen-receptors
WO2021247543A2 (en) 2020-06-02 2021-12-09 10X Genomics, Inc. Nucleic acid library methods
EP4162074B1 (en) 2020-06-08 2024-04-24 10X Genomics, Inc. Methods of determining a surgical margin and methods of use thereof
EP4165207A1 (en) 2020-06-10 2023-04-19 10X Genomics, Inc. Methods for determining a location of an analyte in a biological sample
CN116034166A (en) 2020-06-25 2023-04-28 10X基因组学有限公司 Spatial analysis of DNA methylation
US11761038B1 (en) 2020-07-06 2023-09-19 10X Genomics, Inc. Methods for identifying a location of an RNA in a biological sample
US11981960B1 (en) 2020-07-06 2024-05-14 10X Genomics, Inc. Spatial analysis utilizing degradable hydrogels
US11981958B1 (en) 2020-08-20 2024-05-14 10X Genomics, Inc. Methods for spatial analysis using DNA capture
US11926822B1 (en) 2020-09-23 2024-03-12 10X Genomics, Inc. Three-dimensional spatial analysis
US11827935B1 (en) 2020-11-19 2023-11-28 10X Genomics, Inc. Methods for spatial analysis using rolling circle amplification and detection probes
AU2021409136A1 (en) 2020-12-21 2023-06-29 10X Genomics, Inc. Methods, compositions, and systems for capturing probes and/or barcodes
EP4301870A1 (en) 2021-03-18 2024-01-10 10X Genomics, Inc. Multiplex capture of gene and protein expression from a biological sample
WO2023034489A1 (en) 2021-09-01 2023-03-09 10X Genomics, Inc. Methods, compositions, and kits for blocking a capture probe on a spatial array
CN114199974B (en) * 2021-09-30 2022-08-05 南开大学 Screening method of specific binding target protein based on isomer
CN117288869B (en) * 2023-11-24 2024-02-09 中国医学科学院医药生物技术研究所 Method for detecting p-toluenesulfonate impurities in bulk drug

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000011208A1 (en) * 1998-08-25 2000-03-02 University Of Washington Rapid quantitative analysis of proteins or protein function in complex mixtures

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4433051A (en) * 1981-10-14 1984-02-21 Yeda Research And Development Co., Ltd. Derivatives of α-difluoromethylornithine useful in analysis
US5151164A (en) * 1990-02-09 1992-09-29 The University Of Maryland Enhanced capillary zone electrophoresis and apparatus for performance thereof
US5639603A (en) * 1991-09-18 1997-06-17 Affymax Technologies N.V. Synthesizing and screening molecular diversity
US6114114A (en) * 1992-07-17 2000-09-05 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
US5721099A (en) * 1992-10-01 1998-02-24 Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
US5565324A (en) * 1992-10-01 1996-10-15 The Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
CN1154640C (en) * 1993-10-01 2004-06-23 纽约市哥伦比亚大学理事 Complex combinatorial chemical libraries encoded with tags
US6344328B1 (en) * 1995-12-07 2002-02-05 Diversa Corporation Method for screening for enzyme activity
US6277583B1 (en) * 1996-02-07 2001-08-21 Conjuchem, Inc. Affinity labeling libraries and applications thereof
AU4351897A (en) * 1996-09-16 1998-04-02 Conjuchem, Inc. Affinity labeling libraries with tagged leaving groups
US6132969A (en) * 1998-06-19 2000-10-17 Rosetta Inpharmatics, Inc. Methods for testing biological network models
US6335155B1 (en) 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6197599B1 (en) * 1998-07-30 2001-03-06 Guorong Chin Method to detect proteins
US6391649B1 (en) * 1999-05-04 2002-05-21 The Rockefeller University Method for the comparative quantitative analysis of proteins and other biological material by isotopic labeling and mass spectroscopy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000011208A1 (en) * 1998-08-25 2000-03-02 University Of Washington Rapid quantitative analysis of proteins or protein function in complex mixtures

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ALBECK AMNON ET AL: "Mechanism of cysteine protease inactivation by peptidyl epoxides.", BIOCHEMICAL JOURNAL, vol. 322, no. 3, 1997, pages 879 - 884, XP001015321, ISSN: 0264-6021 *
KAM CHIH-MIN ET AL: "Biotinylated isocoumarins, new inhibitors and reagents for detection, localization, and isolation of serine proteases.", BIOCONJUGATE CHEMISTRY, vol. 4, no. 6, 1993, pages 560 - 567, XP001010582, ISSN: 1043-1802 *
TENORIO D ET AL: "An immunohistochemical investigation of the expression of parathyroid hormone receptors in rat cementoblasts.", ARCHIVES OF ORAL BIOLOGY, vol. 41, no. 3, 1996, pages 299 - 305, XP001015266, ISSN: 0003-9969 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034798B2 (en) 2003-01-16 2015-05-19 Caprotec Bioanalytics Gmbh Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions

Also Published As

Publication number Publication date
WO2001077668A3 (en) 2002-06-06
AU2001224349A1 (en) 2001-10-23
US20020045194A1 (en) 2002-04-18
CA2403296A1 (en) 2001-10-18
US20050287594A1 (en) 2005-12-29
WO2001077684A2 (en) 2001-10-18
EP1275006A2 (en) 2003-01-15
WO2001077668A2 (en) 2001-10-18
JP2003530365A (en) 2003-10-14
US20020064799A1 (en) 2002-05-30
US6872574B2 (en) 2005-03-29
US20020040275A1 (en) 2002-04-04
US20020182652A1 (en) 2002-12-05
AU2001227280A1 (en) 2001-10-23

Similar Documents

Publication Publication Date Title
WO2001077684A3 (en) Proteomic analysis using activity-based probe libraries
Pett-Ridge et al. Using stable isotopes to explore root-microbe-mineral interactions in soil
Christoforou et al. Isobaric tagging approaches in quantitative proteomics: the ups and downs
Arul et al. Sample multiplexing strategies in quantitative proteomics
Cleland et al. A comparison of common mass spectrometry approaches for paleoproteomics
JP3603267B2 (en) Screening natural product samples for novel therapeutic compounds using capillary electrophoresis
Lu et al. Absolute quantification of specific proteins in complex mixtures using visible isotope-coded affinity tags
WO2001027624A3 (en) Compositions and methods for detecting protein modification and enzymatic activity
Sebastiano et al. A new deuterated alkylating agent for quantitative proteomics
EP1379693A4 (en) Bio-barcodes based on oligonucleotide-modified particles
JP2011504596A (en) Internal standards and methods for use in quantitative determination of analytes in samples
Arsène-Ploetze et al. Proteomic tools to decipher microbial community structure and functioning
Iliuk et al. Playing tag with quantitative proteomics
WO2004055491A3 (en) Novel method for sequence determination using nmr
WO2001035072A3 (en) A system for cell-based screening
WO2002063271A3 (en) Activity based probe analysis
Pan et al. Single peptide-based protein identification in human proteome through MALDI-TOF MS coupled with amino acids coded mass tagging
WO2002048674A3 (en) Methods, devices, arrays and kits for detecting and analyzing biomolecules
WO1999055913A3 (en) Reduced complexity nucleic acid targets and methods of using same
Esteban Warren et al. Electrospray ionization tandem mass spectrometry of model peptides reveals diagnostic fragment ions for protein ubiquitination
WO2007076339A3 (en) Isotopically labelled crosslinking agents for the analysis of protein interactions
Wang et al. Integrated capillary isoelectric focusing/nano-reversed phase liquid chromatography coupled with ESI− MS for characterization of intact yeast proteins
Pashkova et al. Coumarin tags for analysis of peptides by MALDI-TOF MS and MS/MS. 2. Alexa Fluor 350 tag for increased peptide and protein identification by LC-MALDI-TOF/TOF MS
WO2000070342A3 (en) Optical system analysis of cells
Ntwali et al. Mass spectrometry-based proteomics of single cells and organoids: The new generation of cancer research

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2403296

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 574487

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001227280

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000990226

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000990226

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000990226

Country of ref document: EP